Cancer Clinical Trials Pathway Model Consensus Meeting – June 13, 2017
Cancer clinical trials are a critical part of bringing new therapies to life. These studies are made possible by patients who agree to participate, allowing
Cancer clinical trials are a critical part of bringing new therapies to life. These studies are made possible by patients who agree to participate, allowing
Researchers in Canada are seeking feedback on your experience with declining or participating in a clinical trial via an on-line, anonymous survey. To
On March 22nd, all Q-CROC liaison coordinators attended the 52nd RALi (Rencontre des agents de liaison) teleconference meeting, along with several members of the Q-CROC
CCTCC Fair Market Value (FMV) Working Group (WG) On March 6th, representatives from several healthcare institutions and pharmaceutical companies met in Toronto
The board of directors of the CHUM Research Centre (CRCHUM) has announced the appointment of Dr. Normand Blais as Assistant Scientific Director of Clinical
Q-CROC welcomes the announcement of the creation of the Oncopole, born from a public-private partnership between the Fonds de recherche du Québec – Santé (FRQS)
From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Stéphanie Ibrahim (CIUSSS du Nord-de-l’Île-de-Montréal),
Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology. CHU Sainte-Justine has positioned itself
The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate cancer tumors in the journal Nature. This project
From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l’Estrie – CHUS), Claire Gagnon (CISSS du Bas-Saint-Laurent), Marie Saint-Jacques (CHU Sainte-Justine),